Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.
The Pediatric end-stage liver disease (PELD) score was developed as a measure of the severity of chronic liver disease that would predict mortality or children awaiting liver transplant. From multivariate analyses a model was derived that included five objective factors which together comprise the PELD score. The factors are growth failure, age less than 1 year, international normalized ratio (INR), serum albumin and total bilirubin.
McDiarmid
Sue V
SV
Department of Pediatrics and Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA. smcdiarmid@mednet.ucla.edu
Merion
Robert M
RM
Dykstra
Dawn M
DM
Harper
Ann M
AM
D002102:Cadaver; D002648:Child; D002908:Chronic Disease; D015276:Health Care Rationing; D006801:Humans; D017093:Liver Failure / Q000145:classification* / Q000601:surgery; D016031:Liver Transplantation; D012720:Severity of Illness Index; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000458:organization & administration*; D014481:United States; D014850:Waiting Lists